Je‐Gun Joung

CHA University Bundang Medical Center — South Korea

Biochemistry, Genetics and Molecular Biology · Life Sciences

31h-index6.6kcitations192works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(61), Lung Cancer Treatments and Mutations(45), RNA modifications and cancer(24), Colorectal Cancer Treatments and Studies(19), Ovarian cancer diagnosis and treatment(18)

Publications192 total

Chemically Defined, Efficient Megakaryocyte Production from Human Pluripotent Stem Cells
Cells·2025Open Access
Clinical Feasibility of Circulating Tumor DNA in Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab
Liver Cancer·2025Open Access
Integrated Multi-Omics Analysis Uncovers Immune–Metabolic Interplay in Hepatocellular Carcinoma Tumor Microenvironment
Cancers·2025· 1 citedOpen Access
Genomic alterations of ground-glass nodular lung adenocarcinoma
UNC Libraries·2025Open Access
Impact of tremelimumab dosing and sequence on tumor immune microenvironment and efficacy of neoadjuvant chemotherapy in advanced ovarian cancer: Insights from the TRU-D/KGOG-3046 study
Gynecologic Oncology·2025
Data from Neoadjuvant Chemotherapy with Dual Immune Checkpoint Inhibitors for Advanced-Stage Ovarian Cancer: Final Analysis of TRU-D Phase II Nonrandomized Clinical Trial
2025Open Access
Study protocol 1 from Neoadjuvant Chemotherapy with Dual Immune Checkpoint Inhibitors for Advanced-Stage Ovarian Cancer: Final Analysis of TRU-D Phase II Nonrandomized Clinical Trial
2025Open Access
Supplementary Data 1 from Neoadjuvant Chemotherapy with Dual Immune Checkpoint Inhibitors for Advanced-Stage Ovarian Cancer: Final Analysis of TRU-D Phase II Nonrandomized Clinical Trial
2025Open Access
Identification of Prognostic Biomarkers of Ovarian High-Grade Serous Carcinoma: A Preliminary Study Using Spatial Transcriptome Analysis and Multispectral Imaging
Cells·2025· 2 citedOpen Access
Neoadjuvant Chemotherapy with Dual Immune Checkpoint Inhibitors for Advanced-Stage Ovarian Cancer: Final Analysis of TRU-D Phase II Nonrandomized Clinical Trial
Clinical Cancer Research·2025· 2 cited
Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial
Gynecologic Oncology·2024· 7 cited
Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): a phase II umbrella trial
2024Open Access
Reply to: Comments on “Randomized, two‐arm, non‐comparative phase 2 study of olaparib plus cediranib or durvalumab in <scp>HRR</scp>‐mutated, platinum‐resistant ovarian cancer: A substudy of <scp>KGOG</scp> 3045”
International Journal of Cancer·2023
Randomized, two‐arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in <scp>HRR</scp>‐mutated, platinum‐resistant ovarian cancer: A substudy of <scp>KGOG</scp> 3045
International Journal of Cancer·2023· 11 citedOpen Access
Triplet maintenance (olaparib, pembrolizumab, and bevacizumab) in <i>BRCA</i> non-mutated patients with platinum-sensitive recurrent ovarian cancer: A multi-center, single-arm phase II study (OPEB-01).
Journal of Clinical Oncology·2023· 1 cited
Supplementary Figure Legends from Molecular Evolution Patterns in Metastatic Lymph Nodes Reflect the Differential Treatment Response of Advanced Primary Lung Cancer
2023Open Access
Supplementary Table S5 from Molecular Evolution Patterns in Metastatic Lymph Nodes Reflect the Differential Treatment Response of Advanced Primary Lung Cancer
2023Open Access
Data from Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC
2023Open Access
Figure S1 from Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer
2023Open Access
Data from Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Woong‐Yang Park(27), Zhangjun Fei(8), Joon Seol Bae(7), Keunchil Park(6), Myung‐Ju Ahn(6), Hae‐Ock Lee(6), Yong Beom Cho(6), Woo Yong Lee(6), Jae‐Yong Nam(6), Jin Seok Ahn(5), Hee Cheol Kim(5), Daeun Ryu(5), Bo Young Oh(5), Hye Hyeon Eum(4), Se‐Hoon Lee(4), Hyun‐Tae Shin(4), Seong Hyeon Yun(4), Jae Won Yun(4), Nayoung K. D. Kim(4), Donghyun Park(4)